Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small-conductance calcium-activated potassium (SK) channels are a subtype of potassium channels that are activated by increases in intracellular calcium concentration. They play a crucial role in regulating the excitability of various cell types, including neurons and cardiomyocytes, by mediating membrane hyperpolarization following action potentials. SK channels are encoded by the KCNN1, KCNN2, and KCNN3 genes, forming homo- or heterotetrameric channel complexes. Activation depends on intracellular Ca²⁺ levels and constitutively bound calmodulin, leading to K⁺ efflux and membrane hyperpolarization. Dysfunctions are implicated in cardiac arrhythmias and neurological disorders.
Potassium efflux leading to membrane hyperpolarization
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small-Conductance Calcium-Activated Potassium Channel (SK channel).